Lauren Gluck, MD

August 14, 2021

Key opinion leaders in multiple sclerosis (MS) discuss the future of relapsing MS management and unmet needs.

August 14, 2021

Expert neurologists discuss current and future biomarkers relevant to relapsing multiple sclerosis including cerebrospinal fluid neurofilament.

August 08, 2021

A panel of experts emphasize the importance of shared decision making in relapsing multiple sclerosis and discuss lifestyle choices that impact the disease.

August 08, 2021

Experts in multiple sclerosis (MS) discuss key factors involved in the sequencing of therapies for relapsing MS.

July 31, 2021

Lauren Gluck, MD discusses considerations for monitoring response to treatment in relapsing multiple sclerosis.

July 31, 2021

Lauren Gluck, MD, and Ravi Dukkipati, MD, provide an overview of teriflunomide for relapsing multiple sclerosis including its safety and tolerability profile.

July 24, 2021

Experts in the field of multiple sclerosis provide insight into the fumarates as a viable oral option for relapsing MS.  

July 24, 2021

A panel of experts discuss the use of anti-CD20 monoclonal antibodies in relapsing multiple sclerosis including summaries of the phase III ORATORIO and ASCLEPIOS trials, for ocrelizumab and ofatumumab, respectively.

July 18, 2021

Expert neurologists discuss the role of sphingosine-1-phosphate (S1P) receptor modulators in relapsing multiple sclerosis including vaccine considerations and pediatric use.

July 18, 2021

Key opinion leaders provide insight into the use cladribine for relapsing multiple sclerosis including durability and safety profile.